Assessment of Efficacy of Calprotectin and Cross-linked N-telopeptides
1 other identifier
interventional
10
0 countries
N/A
Brief Summary
The study aims to assess the efficacy of Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid as a biomarker in patients with peri-implantitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2019
CompletedFirst Posted
Study publicly available on registry
November 26, 2019
CompletedStudy Start
First participant enrolled
December 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2020
CompletedDecember 2, 2019
November 1, 2019
2 months
November 22, 2019
November 27, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Calprotectin concentration in GCF
One of inflammation biomarkers found in gingival crevicular fluid (GCF) that are associated with bone inflammation
3 weeks
Cross-linked N-telopeptides concentration in GCF
One of inflammation biomarkers found in gingival crevicular fluid (GCF) that are associated with bone inflammation
3 weeks
Study Arms (2)
Healthy peri-implant status
OTHERPatient with healthy peri-implant status
Presence of peri-implant diseases
OTHERPatients with presence of peri-implant diseases
Interventions
Sterile paper strips will be used for collecting crevicular fluid
Williams SE manual probe will be used to measure the probing depth
Williams SE manual probe will be used to probe the sulcus a oserve the gingival reaction
Modified Löe and Silness criteria will be used for evaluating the gingival index score
Using modification of criteria described by Schei et al, bone loss rate of alveolar bone will be analyzed on radiographic assessment
Eligibility Criteria
You may not qualify if:
- Patients with history of any systemic illness, metabolic disease.
- Patients with history of antibiotic therapy in past ninety days.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mansour Asserylead
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- No masking
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Consultant in Prosthodontics & Dental Implant
Study Record Dates
First Submitted
November 22, 2019
First Posted
November 26, 2019
Study Start
December 10, 2019
Primary Completion
February 1, 2020
Study Completion
April 1, 2020
Last Updated
December 2, 2019
Record last verified: 2019-11